According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

Wanbury delivers strong Q3 FY26 performance with significant profit growth: Our Bureau, Mumbai Tuesday, February 10, 2026, 17:15 Hrs [IST] Wanbury Ltd, a pharmaceutical company wi ...

Márcio Temtem, Hovione, discusses how his company integrates modular hardware and modeling software to accelerate pharmaceutical R&D and optimize manufacturing processes.

Phlow will manufacture epinephrine API in Virginia while Fresenius Kabi formulates and fills finished doses in existing US ...

Aurobindo Pharma Ltd (BOM:524804) reports robust revenue growth driven by European operations and US injectable sales, while ...

Natco Pharma's Q3 consolidated net profit rose 14.3% YoY to ₹152 crore, while revenue increased by 36.3%, driven by higher export formulations and other operating income.

The Fine and Specialty Chemicals Market is entering a transformative phase of high-value innovation and application-specific customization, underpinned by specialty chemicals’ critical role as ...

Market valued at $16.86B in 2024, projected 4.20% CAGR growth driven by VOC regulation compliance, bio-based adoption, ...

Collaboration aims to leverage Polyrizon’s advanced proprietary intranasal delivery platform to support clinical development of Clearmind’s drug candidate proprietary MEAI ...

Fresenius Kabi and Phlow Corp. have joined forces to onshore the manufacture of Epinephrine Injection, USP in the U.S.

Kashiv BioSciences, LLC ("Kashiv") a vertically integrated biopharmaceutical company, today announced that it has entered ...